Peregrine Asset Advisers »

Cytomx Therapeutics shares owned by Peregrine Asset Advisers

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Peregrine Asset Advisers from 13F filings

Historical chart of Peregrine Asset Advisers investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Peregrine Asset Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Peregrine Asset Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $12k 10k 1.18

More positions owned by Peregrine Asset Advisers

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Oneok (OKE)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Parsons Corporation (PSN)
Modine Manufacturing (MOD)
Sherwin-Williams Company (SHW)
Adtalem Global Ed (ATGE)
Life Time Group Holdings Common Stock (LTH)
Intuitive Surgical Com New (ISRG)
Ge Aerospace Com New (GE)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Primoris Services (PRIM)

View all positions for Peregrine Asset Advisers

Top funds holding Cytomx Therapeutics

Tang Capital Management
Henderson Group
BVF
Vanguard Group
Acadian Asset Management
Assenagon Asset Management
Jacobs Levy Equity Management
Laurion Capital Management
Congress Park Capital
Schonfeld Strategic Advisors
BlackRock
Superstring Capital Management
BlackRock
Renaissance Technologies
Geode Capital Management

View all funds holding Cytomx Therapeutics